For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: October 8–15, 2026
Innovation watch Merck expects faster production of its personalized cancer vaccine. CEO Rob Davis told CNBC the six-week turnaround for…
Blog
This week in health care policy: October 5–9, 2026
Drug pricing and 340B PhRMA sues to block GLOBE. On October 7, PhRMA sued to block the most-favored-nation drug-pricing model…
Blog
New legislation seeks to shuffle the deck chairs on the sinking No Surprises Act
On October 8, Rep. Frank Pallone (D-NJ) introduced the Lower Premiums, Faster Payments Act as a fix for the disastrous No Surprises Act (NSA).
Search Posts
News Release
Population Control Won’t Stop World Hunger
Population control is not the answer to global food shortages, according to the Competitive Enterprise Institute (CEI), a free market think tank. Market-driven innovations in…
Op-Eds
Trashing Free Trade: The Basel Convention’s Impact on International Commerce
Trashing Free Trade: The Basel Convention’s Impact on International Commerce by James M. Sheehan With the establishment of the World Trade Organization (WTO) in 1995,…
Study
Cardiac and Cancer Specialists on the Need for FDA Reform
Two National Polls Debunk The Notion That FDA Doesn't Need Fixing…
News Release
Listen to CEI’s Radio and TV ads on Drug Lag–the delayed availability of new therapies due to FDA regulation
CEI’s radio ad on FDA’s drug approval system, Ocean Storm, is available at: http://cei.org/sites/default/files/CEI_Radio_Storm.mp3 CEI’s television ad is available at:…
Study
Breaking The FDA’s Drug Approval Monopoly:
Executive Summary The Food and Drug Administration’s monopoly over approving new medical therapies is premised on the idea that information markets fail. In…
Op-Eds
Nailed by FDA
I started 1996 with two new experiences. I had a close-up photograph taken of my big toe, and I had my first personal run-in with…